Strides Pharma Science Ltd. - Research Center
532531 STAR Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
617.63 |
520.02 |
540.29 |
475.32 |
563.56 |
Operating profit |
90.79 |
65.66 |
43.27 |
55.56 |
119.44 |
Interest |
46.77 |
44.47 |
40.07 |
36.63 |
42.90 |
Gross profit |
73.66 |
29.87 |
25.54 |
30.59 |
102.91 |
EPS (Rs) |
5.84 |
0.28 |
0.14 |
0.89 |
6.91 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
29.63 |
8.69 |
22.34 |
11.65 |
26.38 |
Stock adjustment |
34.09 |
-36.59 |
-2.43 |
9.55 |
46.76 |
Raw material |
266.45 |
302.14 |
288.94 |
215.10 |
203.55 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
86.60 |
85.66 |
86.25 |
76.70 |
64.53 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
139.71 |
103.15 |
124.27 |
118.40 |
129.29 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
20.81 |
21.06 |
21.34 |
21.46 |
22.71 |
Taxation |
-0.89 |
0.98 |
2.91 |
1.13 |
2.80 |
Net profit / loss |
53.66 |
2.54 |
1.28 |
8.00 |
62.40 |
Extra ordinary item |
-0.07 |
-5.29 |
- |
- |
-15.00 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
91.90 |
91.88 |
90.30 |
90.30 |
90.30 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
14.70 |
12.63 |
8.01 |
11.69 |
21.19 |
GPM (%) |
11.38 |
5.65 |
4.54 |
6.28 |
17.44 |
NPM (%) |
8.29 |
0.48 |
0.23 |
1.64 |
10.58 |